Does immune recognition of SARS-CoV2 epitopes vary between different ethnic groups?

Virus Res. 2021 Sep 21:198579. doi: 10.1016/j.virusres.2021.198579. Online ahead of print.ABSTRACTThe SARS-CoV2 mediated Covid-19 pandemic has impacted humankind at an unprecedented scale. While substantial research efforts have focused towards understanding the mechanisms of viral infection and developing vaccines/ therapeutics, factors affecting the susceptibility to SARS-CoV2 infection and manifestation of Covid-19 remain less explored. Given that the Human Leukocyte Antigen (HLA) system is known to vary among ethnic populations, it is likely to affect the recognition of the virus, and in turn, the susceptibility to Covid-19. To understand this, we used bioinformatic tools to probe all SARS-CoV2 peptides which could elicit T-cell response in humans. We also tried to answer the intriguing question of whether these potential epitopes were equally immunogenic across ethnicities, by studying the distribution of HLA alleles among different populations and their share of cognate epitopes. Results indicate that the immune recognition potential of SARS-CoV2 epitopes tend to vary between different ethnic groups. While the South Asians are likely to recognize higher number of CD8-specific epitopes, Europeans are likely to identify higher number of CD4-specific epitopes. We also hypothesize and provide clues that the newer mutations in SARS-CoV2 are unlikely to alter the T-cell mediated immunogenic responses among the studied ethnic populations. The work presented herein is expected ...
Source: Virus Research - Category: Virology Authors: Source Type: research

Related Links:

Scientists at MIT announced the development of a rapid COVID-19 test that can detect the virus in a saliva sample in as little as five minutes. The technology does not require antibodies or other expensive reagents typically associated with protein d...
Source: Medgadget - Category: Medical Devices Authors: Tags: Materials Medicine Nanomedicine Public Health mit Source Type: blogs
son The current COVID-19 pandemic has highlighted the need for the research community to develop a better understanding of viruses, in particular their modes of infection and replicative lifecycles, to aid in the development of novel vaccines and much needed anti-viral therapeutics. Several viruses express proteins capable of forming pores in host cellular membranes, termed “Viroporins”. They are a family of small hydrophobic proteins, with at least one amphipathic domain, which characteristically form oligomeric structures with central hydrophilic domains. Consequently, they can facilitate the transport of...
Source: Viruses - Category: Virology Authors: Tags: Review Source Type: research
COVID-19 vaccines are already authorized for children ages 12 and older, and the shots now have the support of a U.S. Food and Drug Administration (FDA) expert panel for younger children ages 5 to 11. In a 17 to 0 vote, with one abstention, the committee recommended the COVID-19 vaccine made by Pfizer-BioNTech for the youngest group yet to potentially get immunized against the disease in the US. The committee recommended a two-dose regimen at one-third the dosage approved for adults. The FDA now takes the committee’s advice into consideration before making a final recommendation. If the agency decides to recommend th...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Source Type: news
J Virol Methods. 2021 Oct 23:114341. doi: 10.1016/j.jviromet.2021.114341. Online ahead of print.ABSTRACTThe COVID-19 pandemic has demanded a range of biotechnological products for detection of SARS-CoV-2 variants and evaluation of human seroconversion after infection or vaccination. In this work, we describe an easy pipeline for expression of SARS-CoV-2 nucleocapsid (N) protein in insect cells followed by its purification via affinity chromatography. The N gene was cloned into the genome of Autographa californica multiple nucleopolyhedrovirus (AcMNPV) via transposition and the resulting recombinant baculovirus was used for...
Source: Journal of Virological Methods - Category: Virology Authors: Source Type: research
Cancer Invest. 2021 Oct 26:1-25. doi: 10.1080/07357907.2021.1995742. Online ahead of print.ABSTRACTPatients with cancer are at significantly greater risk of COVID-19 and its complications than the general population. Since IgG antibodies remain detectable well after infection with the SARS-CoV-2 virus, seroprevalence can be used to estimate the proportion of the cancer population previously infected and potentially immune to SARS-CoV-2. The current study is a multi-center, prospective observational study to assess seroprevalence of SARS-CoV-2 IgG antibody in a cancer population referred for vaccination between April and Ju...
Source: Cancer Investigation - Category: Cancer & Oncology Authors: Source Type: research
AbstractDeferring nonemergent cardiac surgery became the strategy of choice for several international healthcare systems afflicted by high case burdens of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) to both conserve valuable healthcare resources and protect patients from possible exposure. Missing from the available dataset to help guide policy development has been a clear understanding of the extent to which COVID-19 infection modulates cardiac surgery outcomes. In their investigation, Bonalumi et al. uncovered an inpatient COVID-19 positivity rate of almost 10 times higher than that of the gener...
Source: Journal of Cardiac Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: COMMENTARY Source Type: research
Molecules, Vol. 26, Pages 6455: A Review of Human Coronaviruses’ Receptors: The Host-Cell Targets for the Crown Bearing Viruses Molecules doi: 10.3390/molecules26216455 Authors: Aaya Nassar Ibrahim M. Ibrahim Fatma G. Amin Merna Magdy Ahmed M. Elgharib Eman B. Azzam Filopateer Nasser Kirllos Yousry Israa M. Shamkh Samah M. Mahdy Abdo A. Elfiky A novel human coronavirus prompted considerable worry at the end of the year 2019. Now, it represents a significant global health and economic burden. The newly emerged coronavirus disease caused by the severe acute respiratory syndrome coronavirus-2...
Source: Molecules - Category: Chemistry Authors: Tags: Review Source Type: research
The impressive success of mass vaccination in curtailing the coronavirus 2 (SARS-CoV-2) by halting transmission has paved the road for returning to “pre-pandemic life”. However, several open questions challenge the triumph of controlling the pandemic by vaccination. One major concern is the ability of the virus to mutate and evolve; this potentially can cause SARS-CoV-2 to partially evade the immune system, reducing vaccine effectiveness (V E) in preventing disease and viral transmission. Determining VE against variants of concern (VOC)1 is vital for planning and modifying vaccination strategies.
Source: Journal of Clinical Epidemiology - Category: Epidemiology Authors: Tags: Original Article Source Type: research
This article is protected by copyright. All rights reserved.PMID:34695227 | DOI:10.1002/eji.202149619
Source: European Journal of Immunology - Category: Allergy & Immunology Authors: Source Type: research
Given the urgent need for coronavirus disease 2019 therapeutics, early in the pandemic the Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership rapidly designed a unique therapeutic agent intake and assessment process for candidate treatments of coronavirus disease 2019. These treatments included antivirals, immune modulators, severe acute respiratory syndrome coronavirus 2 neutralizing antibodies, and organ-supportive treatments at both the preclinical and clinical stages of development. The ACTIV Therapeutics-Clinical Working Group Agent Prioritization subgroup e...
Source: Critical Care Medicine - Category: Emergency Medicine Tags: Review Article Source Type: research
More News: Allergy & Immunology | COVID-19 | Pandemics | SARS | Vaccines | Virology